MedTrace Logo

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

NCT02630082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2015-12-15

No results posted yet for this study

Summary

Rectal and genital sampling in HIV prevention trials permits assessments at the site of HIV entry. Yet the safety and acceptability of circumcision and sigmoidoscopy (and associated abstinence recommendations) are unknown in uncircumcised men who have sex with men (MSM) at high risk of HIV infection. The purpose of this study is to evaluate the feasibility of methods for assessing baseline characteristics of the mucosa of MSM at risk of HIV infection in Lima, Peru.

Conditions

  • HIV Infections
  • Acquired Immunodeficiency Syndrome
  • Lentivirus Infections
  • Retroviridae Infections
  • RNA Virus Infections
  • Virus Diseases
  • Sexually Transmitted Diseases, Viral
  • Sexually Transmitted Diseases
  • Immunologic Deficiency Syndromes
  • Immune System Diseases
  • Slow Virus Diseases

Interventions

PROCEDURE

Circumcision

PROCEDURE

Flexible sigmoidoscopy

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02630082 on ClinicalTrials.gov